SCHEMBL7212979

SCHEMBL7212979

NCCCCCc1ccc(NS(=O)(=O)c2ccc(Cl)cc2Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.57
MAPT P10636 2/20 0.52
MEN1 O00255 1/20 0.52
LMNA P02545 1/20 0.52
ALOX12 P18054 1/20 0.52
KMT2A Q03164 1/20 0.52
NLRP1 Q9C000 1/20 0.52
ITGA1 P56199 4/20 0.51
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
HDAC1 Q13547 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
PPARG P37231 4/20 0.47
TP53 P04637 1/20 0.47
IDH1 O75874 1/20 0.45
HTR6 P50406 1/20 0.43
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7213002 0.88 ACLY (0.49) ACLYCA1CA2CA7CA9
Propane SCHEMBL7212983 0.86 TP53 (0.54) ACLYMAPTMEN1LMNAALOX12
SCHEMBL7208106 0.82 CES1 (0.61) HDAC1HTR6ALDH1A1HTT
SCHEMBL3267231 0.79 ITGA1 (0.61) ACLYMAPTMEN1LMNAALOX12
SCHEMBL28121241 0.77 MAPT (0.63) MAPTMEN1LMNAALOX12KMT2A
SCHEMBL7212972 0.77 ACLY (0.53) ACLYMAPTMEN1LMNAALOX12
SCHEMBL4128136 0.74 CYP3A4 (0.58) MAPTMEN1LMNAKMT2ATP53
Propane SCHEMBL7213006 0.74 CA1 (0.49) ACLYMAPTLMNACA1CA2
SCHEMBL94831 0.74 MAPT (0.63) MAPTMEN1LMNAALOX12KMT2A
SCHEMBL14018772 0.74 MAPT (0.63) MAPTMEN1LMNAALOX12KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077935-B1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS UPJOHN CO (US) 2003-10-29 EP claimed
EP-1077935-A1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS PHARMACIA & UPJOHN COMPANY (US) 2001-02-28 EP claimed
US-6103766-A SUBSTITUTED OR UNSUBSTITUTED PHENYLSULFONAMIDE-PHENYLAMINE DERIVATIVES USEFUL FOR TREATING THE DISORDERS RELATED TO CENTRAL NERVOUS SYSTEM PHARMACIA & UPJOHN COMPANY (US) 2000-08-15 US claimed
WO-1999058499-A1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS PHARMACIA & UPJOHN COMPANY (US) 1999-11-18 WO claimed
EP-1077935-B1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS UPJOHN CO (US) 2003-10-29 EP disclosed
EP-1077935-A1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS PHARMACIA & UPJOHN COMPANY (US) 2001-02-28 EP disclosed
US-6103766-A SUBSTITUTED OR UNSUBSTITUTED PHENYLSULFONAMIDE-PHENYLAMINE DERIVATIVES USEFUL FOR TREATING THE DISORDERS RELATED TO CENTRAL NERVOUS SYSTEM PHARMACIA & UPJOHN COMPANY (US) 2000-08-15 US disclosed
WO-1999058499-A1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS PHARMACIA & UPJOHN COMPANY (US) 1999-11-18 WO disclosed